UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D/A
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1)*
AnorMED Inc.
------------------------------------------------------------------------------
(Name of Issuer)
Common Shares Without Par Value
------------------------------------------------------------------------------
(Title of Class of Securities)
035910108
------------------------------------------------------------------------------
(CUSIP Number)
Brett Spector
SuttonBrook Capital Management LP
598 Madison Avenue
6th Floor
New York, NY 10022
(212) 588-6622
------------------------------------------------------------------------------
(Name, Address and Telephone Number of Persons Authorized to
Receive Notices and Communications)
November 7, 2006
------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check
the following box |_|.
*The remainder of this cover page will be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but will be subject to all other provisions of the
Act (however, see the Notes).
SCHEDULE 13D
-------------------------- -----------------------
CUSIP No. 035910108 Page 2 of 8
-------------------------- -----------------------
------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
SUTTONBROOK CAPITAL MANAGEMENT LP
------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_|
(b) |_|
------------------------------------------------------------------------------
3 SEC USE ONLY
------------------------------------------------------------------------------
4 SOURCE OF FUNDS
AF
------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) |_|
------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
0
SHARES
-------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 0
-------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
0
REPORTING
-------------------------------------------------------------
PERSON 10 SHARED DISPOSITIVE POWER
WITH 0
------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES |_|
------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
PN
------------------------------------------------------------------------------
SCHEDULE 13D
-------------------------- -----------------------
CUSIP No. 035910108 Page 3 of 8
-------------------------- -----------------------
------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
SUTTONBROOK CAPITAL PORTFOLIO L.P.
------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_|
(b) |_|
------------------------------------------------------------------------------
3 SEC USE ONLY
------------------------------------------------------------------------------
4 SOURCE OF FUNDS
WC, OO
------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) |_|
------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
CAYMAN ISLANDS
------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
0
SHARES
-------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 0
-------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
0
REPORTING
-------------------------------------------------------------
PERSON 10 SHARED DISPOSITIVE POWER
WITH 0
------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES |_|
------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
PN
------------------------------------------------------------------------------
SCHEDULE 13D
-------------------------- -----------------------
CUSIP No. 035910108 Page 4 of 8
-------------------------- -----------------------
------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
JOHN LONDON
------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_|
(b) |_|
------------------------------------------------------------------------------
3 SEC USE ONLY
------------------------------------------------------------------------------
4 SOURCE OF FUNDS
AF
------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) |_|
------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED STATES
------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
0
SHARES
-------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 0
-------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
0
REPORTING
-------------------------------------------------------------
PERSON 10 SHARED DISPOSITIVE POWER
WITH 0
------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES |_|
------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
------------------------------------------------------------------------------
SCHEDULE 13D
-------------------------- -----------------------
CUSIP No. 035910108 Page 5 of 8
-------------------------- -----------------------
------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
STEVEN M. WEINSTEIN
------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_|
(b) |_|
------------------------------------------------------------------------------
3 SEC USE ONLY
------------------------------------------------------------------------------
4 SOURCE OF FUNDS
AF
------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) |_|
------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED STATES
------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
0
SHARES
-------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 0
-------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
0
REPORTING
-------------------------------------------------------------
PERSON 10 SHARED DISPOSITIVE POWER
WITH 0
------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES |_|
------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
------------------------------------------------------------------------------
This Amendment No. 1 to Schedule 13D amends certain information contained
in the Schedule 13D dated September 27, 2006 and filed on September 27,
2006 (the "Schedule 13D") by SuttonBrook Capital Management LP (the
"Investment Manager"), SuttonBrook Capital Portfolio L.P. (the "Master
Fund"), John London ("Mr. London") and Steven M. Weinstein ("Mr. Weinstein"
and, together with the Investment Manager, the Master Fund and Mr. London,
the "Filing Persons") relating to the common shares without par value (the
"Common Stock"), of AnorMED Inc., a Canadian corporation (the "Company").
Capitalized terms used but not defined herein have the meanings ascribed to
them in the Schedule 13D.
ITEM 5. INTERESTS IN SECURITIES OF THE ISSUER.
-------------------------------------
Item 5 is amended as follows:
(a) As of November 7, 2006, the Filing Persons are no longer
beneficial owners of any shares of Common Stock.
(b) As of November 7, 2006, none of the Filing Persons have the power
to vote or direct the vote with respect to, or to dispose or direct the
disposition of, any shares of Common Stock.
(c) On November 7, 2006, each of the Filing Persons tendered its
shares of Common Stock into the tender offer by Dematal Corp, a Nova Scotia
unlimited company and a wholly-owned subsidiary of Genzyme Corporation, a
Massachusetts corporation at a price of $13.50 per share of Common Stock.
Genzyme Corporation announced on November 7, 2006 that all shares of Common
Stock tendered into the tender offer were accepted for payment. Upon such
acceptance, the Filing Persons ceased to own, beneficially or otherwise,
any shares of Common Stock.
(d) Not applicable.
(e) As of November 7, 2006, the Filing Persons are no longer
beneficial owners of any shares of Common Stock. Accordingly, this
amendment is the final amendment to Schedule 13D.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
November 9, 2006
SuttonBrook Capital Management LP
By: SuttonBrook Holdings LLC,
Its General Partner
By: /s/ John London
------------------------------------
Name: John London
Title: Managing Member
SuttonBrook Capital Portfolio L.P.
By: SuttonBrook Capital Partners LP,
Its General Partner
By: SuttonBrook Capital Associates LP,
Its General Partner
By: SuttonBrook Capital Associates LLC,
Its General Partner
By: /s/ John London
--------------------------
Name: John London
Title: Managing Member
/s/ John London
----------------------------------
John London
/s/ Steven M. Weinstein
----------------------------------
Steven M. Weinstein
EXHIBIT 1 - JOINT FILING AGREEMENT
Joint Filing Agreement
The undersigned hereby agree that this Amendment No. 1 to Schedule 13D
filed herewith relating to the common shares without par value of AnorMED
Inc., is being filed jointly with the Securities and Exchange Commission
pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as
amended, on behalf of each of the undersigned.
This Agreement may be executed in counterparts and each of such
counterparts taken together shall constitute one and the same instrument.
November 9, 2006
SuttonBrook Capital Management LP
By: SuttonBrook Holdings LLC,
Its General Partner
By: /s/ John London
------------------------------------
Name: John London
Title: Managing Member
SuttonBrook Capital Portfolio L.P.
By: SuttonBrook Capital Partners LP,
Its General Partner
By: SuttonBrook Capital Associates LP,
Its General Partner
By: SuttonBrook Capital Associates LLC,
Its General Partner
By: /s/ John London
--------------------------
Name: John London
Title: Managing Member
/s/ John London
----------------------------------
John London
/s/ Steven M. Weinstein
----------------------------------
Steven M. Weinstein